Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Humacyte ( (HUMA) ) just unveiled an announcement.
On May 4, 2026, Humacyte, Inc. disclosed that it had received a notice from Nasdaq after its common stock traded below the $1.00 minimum bid price requirement for 30 consecutive business days ended May 1, 2026, putting its Nasdaq Global Select Market listing at risk under Nasdaq Listing Rule 5450(a)(1). On June 5, 2026, the company announced that Nasdaq had notified it of regained compliance with the $1.00 minimum bid requirement, confirming continued inclusion on the Nasdaq Global Select Market and closing the listing deficiency matter.
The most recent analyst rating on (HUMA) stock is a Buy
with a $2.00 price target.
To see the full list of analyst forecasts on Humacyte stock,
see the HUMA Stock Forecast page.
Spark’s Take on HUMA Stock
According to Spark, TipRanks’ AI Analyst, HUMA is a Neutral.
The score is held down primarily by very weak financial performance (minimal revenue, large losses, heavy cash burn, and high leverage vs. equity). Technicals are a relative positive with price above key moving averages and positive MACD, but momentum looks stretched (high Stoch/RSI). Earnings-call updates add moderate support via improving unit sales, cost reductions, and near-term clinical/regulatory catalysts, while valuation remains constrained by ongoing losses and no dividend.
To see Spark’s full report on HUMA stock,
click here.
More about Humacyte
Humacyte, Inc. operates in the biotechnology sector, focusing on developing engineered human tissues and regenerative medical products. The company’s shares are listed on The Nasdaq Global Select Market, providing access to public equity markets and visibility among institutional and retail investors.
Average Trading Volume: 7,457,024
Technical Sentiment Signal: Hold
Current Market Cap: $310.8M
Learn more about HUMA stock on TipRanks’ Stock Analysis page.